A Clinical Prognostic Score to Predict Survival of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Receiving First-Line Chemotherapy: A Retrospective Analysis

机译：预测一线化疗的晚期或转移性非小细胞肺癌（NSCLC）患者生存率的临床预后评分：回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAlthough several complicated models have been built to evaluate the prognosis of NSCLC patients receiving chemotherapy, simple economic models are still needed to give a preliminary survival assessment of these patients.

机译：背景技术尽管已经建立了几种复杂的模型来评估接受化疗的NSCLC患者的预后，但仍需要简单的经济模型来对这些患者进行初步生存评估。

著录项

期刊名称 Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
作者
Jing Gong; Ling Xu; Zhi Li; Xuejun Hu; Jing Liu; Yuee Teng; Bo Jin; Mingfang Zhao; Jing Shi; Tianshu Guo; Xiaonan Shi; Yu Cheng; Yunpeng Liu; Xiujuan Qu;
展开▼
作者单位

展开▼
年(卷),期 1923(24),
年度 1923
页码 8264–8271
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
Lung Neoplasms, Overall, Prognosis, Survival;

机译：肺肿瘤;总体;预后;生存;

相似文献

外文文献
中文文献
专利

1. 吉非替尼治疗局部晚期或转移性非小细胞肺癌患者疗效及生存的临床预测因素——两项Ⅱ期临床研究的综合分析 [J] . 赵媛媛, 张阳, 赵洪云, 癌症（英文版） . 2009,第006期
2. Predictive value of APE1, BRCA1, E1CC1 and TUBB3_ expression In patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paditaxel chemotherapy [J] . Zheng Li, Yi Qing, Wei Guan, Cancer chemotherapy and pharmacology. . 2014,第4期

机译：APE1，BRCA1，E1CC1和TUBB3_表达的预测价值在接受一线铂-帕他赛尔化疗的晚期非小细胞肺癌（NSCLC）患者中
3. Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy [J] . Jie Shen, Yuanqing Ye, David W. Chang, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第期

机译：循环代谢物型材以预测接受一线化疗的先进非小细胞肺癌患者的整体存活
4. 6560 POSTER Prognostic factors affecting survival on pretreated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) – Subgroup analysis in a randomized Ph II study of pemetrexed 500 mg/m2 and 1000 mg/m2 [J] . T.Okabe, K.Kubota, T.Tamura, European Journal of Cancer Supplements . 2007,第4期

机译：6560 POSTER影响预治疗的局部晚期或转移性非小细胞肺癌（NSCLC）患者生存率的预后因素–培美曲塞500 mg / m2 和1000 mg / m2
5. Does Sex Make a Difference in Survival of Patients Undergoing Resection for Early Stage Non-Small Cell Lung Cancer (NSCLC)? [C] . Steven J.Jubelirer, Nicole L.Varela, Christine A.Welch, 21st international conference on screening for lung cancer . 2009

机译：性别对早期非小细胞肺癌（NSCLC）切除患者的生存率有影响吗？
6. Predictors of changes in health-related quality of life during chemotherapy in an advanced non-small cell lung cancer patient population [D] . Shallwani, Shirin Mehdi 2010

机译：非小细胞肺癌晚期患者化疗期间健康相关生活质量变化的预测因子
7. Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy [O] . Jie Shen, Yuanqing Ye, David W. Chang, -1

机译：循环代谢物谱可预测接受一线化疗的晚期非小细胞肺癌患者的总体生存率
8. A Clinical Prognostic Score to Predict Survival of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Receiving First-Line Chemotherapy: A Retrospective Analysis [O] . Jing Gong, Ling Xu, Zhi Li, 2018

机译：预测前期或转移性非小细胞肺癌（NSCLC）患者的临床预后评分，接受一线化疗的患者：回顾性分析

A Clinical Prognostic Score to Predict Survival of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Receiving First-Line Chemotherapy: A Retrospective Analysis

摘要

著录项

相似文献

相关主题

期刊订阅